Novartis receives Morrison & Foerster advice on Camurus deal
The global law firm, Morrison & Foerster has advised Novartis to sign an exclusive...
Mymetics regains intra-nasal influenza vaccine from Solvay
Mymetics, a developer of next-generation preventative vaccines, has regained its intra-nasal influenza vaccine from Solvay.Mymetics...
The Medicines Company introduces new Cleviprex formulation
The Medicines Company has launched a new twelve hour formulation for the FDA approved Cleviprex...
Theraclone doses first patient in Phase 1 TCN-032 drug trial
Theraclone Sciences has dosed first patient in a randomized, double-blind, dose-escalation Phase 1 trial...
FDA approves Amphastar Enoxaparin Sodium Injection
The US Food and Drug Administration has approved Amphastar Pharmaceuticals' abbreviated new drug application...
Dey Pharma to provide EpiPen Auto-Injectors
Mylan's subsidiary Dey Pharma is set to offer EpiPen 2-Pak and EpiPen Jr 2-Pak (epinephrine)...
Unilife develops safety syringe to reconstitute lyophilized drugs
Unilife has developed Unifill EZMix multiple-chamber ready-to-fill (prefilled) safety syringe for lyophilized drugs and vaccines...
Allos recruits first patient in Phase 3 PTCL drug trial
Allos Therapeutics has recruited first patient in a Phase 3 multi-center, randomized, open-label (PDX-017) Phase...
Abbott two new strengths of CPP drug gets FDA nod
Abbott has received the US Food and Drug Administration (FDA) approval for two new strengths...
AVI BioPharma starts patient dosing in DMG drug Phase 2 trial
AVI BioPharma has started patient dosing in a placebo-controlled Phase 2 trial to evaluate eteplirsen...
